Gastric Cancer Diagnostics Market Size Worth USD 2.78 Billion by 2034 | CAGR: 7.7%

The global gastric cancer diagnostics market size is expected to reach USD 2.78 billion by 2034, according to a new study by Polaris Market Research. The report “Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The gastric cancer diagnostics market focuses on the various methods and technologies used to detect and confirm stomach cancer. This involves a range of medical tests, procedures, and evaluations that healthcare professionals use to identify the disease in its early stages, determine its spread, and guide appropriate treatment plans. These diagnostic approaches include imaging studies, endoscopic examinations, tissue biopsies, blood tests, and advanced molecular analyses, all aimed at providing an accurate and timely diagnosis.

The gastric cancer diagnostics market growth is attributed to the increasing number of gastric cancer cases around the world, which naturally leads to a higher demand for diagnostic services. Additionally, there is a growing emphasis on early detection through screening programs, as finding the cancer early often improves treatment success. The industry is also benefiting from ongoing technological advancements, with newer, more precise, and less invasive diagnostic tools becoming available, which helps identify the disease more effectively and tailoring treatments to individual patients.

Have Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/gastric-cancer-diagnostics-market/request-for-sample

Gastric Cancer Diagnostics Market Report Highlights

• By product, the reagents & consumables segment held the largest share in 2024 as reagents and consumables are essential for almost every diagnostic test, from routine blood work to advanced molecular analyses.
• By disease type, the adenocarcinoma segment held the largest share in 2024, due to its overwhelming prevalence as the most common form of gastric cancer. The majority of diagnostic efforts and resource allocation are naturally directed toward identifying and characterizing this widespread disease type.
• By end use, the hospitals segment held the largest share in 2024 as they are the primary healthcare facilities where patients typically receive initial diagnoses, undergo endoscopic procedures, and access comprehensive diagnostic infrastructure.
• The North America gastric cancer diagnostics market accounted for the largest share in 2024, due to advanced healthcare infrastructure, high awareness regarding early diagnosis, and a strong focus on precision medicine. The market in Asia Pacific is expanding rapidly, driven by the highest global incidence of gastric cancer, particularly in East Asian countries.
• A few key players in the market include F. Hoffmann-La Roche Ltd.; Abbott Laboratories; QIAGEN; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Illumina, Inc.; Myriad Genetics, Inc.; Mirxes Pte. Ltd.; Vela Diagnostics; BIOMÉRIEUX; and AI Medical Service Inc.

Polaris Market Research has segmented the gastric cancer diagnostics market report on the basis of product, disease type, end use, and region:

By Product Outlook (Revenue – USD Billion, 2020–2034)

• Reagents & Consumables
• Instruments

By Disease Type Outlook (Revenue – USD Billion, 2020–2034)

• Adenocarcinoma
• Gastric lymphoma
• Others

By End Use Outlook (Revenue – USD Billion, 2020–2034)

• Hospitals
• Diagnostic Laboratories
• Diagnostic Imaging

By Regional Outlook (Revenue – USD Billion, 2020–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America